<?xml version="1.0" encoding="UTF-8"?>
<ref id="B91">
 <label>91</label>
 <element-citation publication-type="webpage">
  <person-group person-group-type="author">
   <name>
    <surname>Kandeel</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Abdelrahman</surname>
    <given-names>AHM</given-names>
   </name>
   <name>
    <surname>Oh-Hashi</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Ibrahim</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Venugopala</surname>
    <given-names>KN</given-names>
   </name>
   <name>
    <surname>Morsy</surname>
    <given-names>MA</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease</article-title>
  <source>J Biomol Struct Dyn</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1080/07391102.2020.1784291</pub-id>
 </element-citation>
</ref>
